Investor Frustratio...
Health Care: Drugs
Salix Pharmaceuticals Ltd. (SLXP: NASDAQ)
$50.50 0.93 | 1.88%
05/24/12 - 04:00 PM ET
845.41K / 934.60K
Vol / Avg. Vol:49.79 / 49.57
Open / Prev. Close:49.04 - 50.50
Today's Range:25.64 - 53.99
52 Wk Range:5.54%
Performance YTD:TheStreet Rating:
Portfolios with SLXP
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ProDiscovery Capital Management
- ContributorBreakout Stocks Of The Week...
- Contributor10 Pharma Stocks With Upside
- Contributor10 Biotech Stocks Facing FD...
- UserTop Healthcare Short Squeez...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
- UserBarron's Research Reports 3...
- Usercazzconsult Portfolio 1
Latest SLXP Headlines from TheStreet
- Salix Pharmaceuticals Ltd. (SLXP): Today's Featured Health Care Winner 05.08.12 | 04:05 pm
- Salix Stock Hits New 52-Week High (SLXP) 03.26.12 | 10:03 am
- Salix Reaches New 52-Week High (SLXP) 03.15.12 | 05:03 pm
- Salix Rises On Unusually High Volume (SLXP) 03.13.12 | 04:03 pm
- 5 Stocks Poised for Breakouts 02.28.12 | 01:02 pm
- Salix Stock Hits New 52-Week High (SLXP) 02.28.12 | 11:02 am
- The Week Ahead: GDP, Priceline, Manufacturing Data
02.26.12 | 04:02 pm - Salix Stock Hits New 52-Week High (SLXP) 01.10.12 | 09:01 am
- Analysts' Actions: EXPE, WAG, UAL, RE 12.23.11 | 09:12 am
- Salix Stock Gaps Up On Today's Open (SLXP) 12.20.11 | 09:12 am
Press Releases for SLXP
- Salix Pharmaceuticals Outlines Data Presentations At Digestive Disease Week 2012 - Business Wire 05.18.12 | 07:05 am
- Salix Pharmaceuticals Reports 1Q2012 Results - Business Wire 05.07.12 | 04:05 pm
- Salix Pharmaceuticals Announces Extension Of Crofelemer NDA Priority Review - Business Wire 04.30.12 | 02:04 pm
- Salix And Progenics Announce FDA Extension Of RELISTOR® SNDA Goal Date To July 27, 2012 - Business Wire 04.25.12 | 08:04 am
- Salix Pharmaceuticals Announces 1Q2012 Financial Results Conference Call And Webcast - Business Wire 04.23.12 | 07:04 am
- Salix Pharmaceuticals Closes Sale Of Convertible Notes - Business Wire 03.16.12 | 01:03 pm
- Salix Pharmaceuticals Prices Convertible Notes Offering - Business Wire 03.13.12 | 09:03 am
- Salix Pharmaceuticals Announces Proposed Convertible Notes Offering - Business Wire 03.12.12 | 04:03 pm
- Salix Pharmaceuticals To Present At Cowen Health Care Conference - Business Wire 02.28.12 | 07:02 am
- Salix Pharmaceuticals Reports 4Q And FY2011 Results - Business Wire 02.27.12 | 04:02 pm
Partner Headlines for SLXP
- The Definitive Biotech ETF Guide (IBB, XBI, FBT) - Benzinga 05.21.12 | 01:05 pm
- Medical Stocks Forming Bases Amid Market Sell-Off - Investor's Business Daily 05.18.12 | 06:05 pm
- The Zacks Analyst Blog Highlights: US Airways Group, United Continental Holdings, Delta Airlines, Salix Pharmaceuticals and Progenics Pharmaceuticals - Press Releases - Zacks 04.24.12 | 09:04 am
- Spain, China Woes Spark Selling; Alcoa Beats Views - Investor's Business Daily 04.10.12 | 04:04 pm
- Stocks Sharply Lower In Late Afternoon; Apple Dips - Investor's Business Daily 04.10.12 | 03:04 pm
- Indexes' Losses Pick Up in Afternoon; Apple Off Highs - Investor's Business Daily 04.10.12 | 01:04 pm
- Stocks Fall Broadly At Midday, But Apple Keeps Rising - Investor's Business Daily 04.10.12 | 12:04 pm
- Stocks Dip To Quiet Losses; Dell, Cree, Best Buy Gain - Investor's Business Daily 04.10.12 | 10:04 am
- What's It Going To Take To Get Salix Cheap? - Seeking Alpha 02.29.12 | 08:02 am
- Progenics Should Outperform The Market In The Short Term - Seeking Alpha 02.15.12 | 08:02 am
